logo
Matt Canavan's leadership tilt questioned

Matt Canavan's leadership tilt questioned

Mercury10-05-2025
Former Labor adviser Bruce Hawker has weighed in on Matt Canavan's bid to challenge David Littleproud for the leadership of the Nationals following the Coalition's federal election defeat.
The Queensland Senator confirmed he will vie for Nationals leader when the party room meets on Monday in Canberra amid Jacinta Price's defection to the Liberals.
"He's very conservative, he's a bit of a disruptor. Again, somebody who probably isn't reading the room particularly well when it comes to where the Australian public is right now," Mr Hawker told Sky News Australia.
"I think if I were the National party, I'd be trying to settle things down a bit, looking to get in touch with their own electors who obviously have some concerns as well.
"They have to be looking all the time at their own base just like the other parties do too ... if I were them, I think I'd probably stick with Littleproud."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Private R&D investment by Australian businesses falling, report finds ahead of roundtable
Private R&D investment by Australian businesses falling, report finds ahead of roundtable

West Australian

time4 hours ago

  • West Australian

Private R&D investment by Australian businesses falling, report finds ahead of roundtable

Private investment into research and development in Australian businesses is slipping backwards and comparatively lower to similar other nations, a new report shows. The report — collated by the Business Council of Australia ahead of Treasurer Jim Chalmer's productivity roundtable next month — identified a raft of targeted policies to boost business potential. It proposes offering extra incentives for collaboration and commercialisation, cutting red tape, and consolidating grants into major national programs. The report estimates that for every $1 spent on R&D, it generates $5 in economic value and $7 billion in gross domestic product (GDP) annually. If the suite of measures are implemented, it's expected to grow productivity in Australia 0.1 per cent each year. It also recommends a simpler R&D Tax Incentive by standardising tax offsets of 18.5 per cent above the company rate and removing its current $150 million cap. It's hoped having a single, consistent rule rather than the current different benefit rates depending on company size or how much they spend, would encourage firms to invest in R&D, especially smaller players. As for scrapping the cap, the policy is designed to allow businesses to claim tax offsets for all of their eligible R&D spend rather than just the first $150 million under the current framework. BCA chief executive Bran Black said the targeted policies were designed to fix Australia's productivity problems by unlocking investment, boosting jobs and wages. He said reversing the current trend, which has seen R&D investment drop 24 per cent in the last decade, would help drive innovation and productivity nationally. He said it was important businesses were given the 'right environment' to invest: 'If we don't act now then we will keep losing innovators, capital and ideas to other nations'. 'Better tax, collaboration and commercialisation policies will give businesses the confidence to take the next step and create new Australian technologies that benefit everyone's lives,' he said. The report will form part of a joint industry submission with well-known Australian software firm Atlassian and medical device company Cochlear. Cochlear chief executive and president Dig Howitt said policy reform and 'well-funded strategies' would be critical to unlocking more R&D in Australia. Atlassian chief of staff Amy Glancey said by supporting major companies to invest in R&D it would have a trickle down effect to create a better environment for entrepreneurship and innovation. Dr Chalmer's roundtable will be held at Parliament House August 19–21 and is expected to shape a shared agenda on improving productivity, strengthening budget sustainability, and building economic resilience. It has prompted a number of state-level consultations and spin-off roundtables, including one held on Friday by Independent MP Allegra Spender involving economists and industry figures in Canberra. The BCA, along with other industry bodies, companies, and government representatives, are finalising submissions ahead of the August roundtable, outlining ideas across tax, regulation, innovation, skills, and digital transformation to help lift Australia's productivity.

Government to introduce legislation for cheaper PBS medicines next week as parliament resumes
Government to introduce legislation for cheaper PBS medicines next week as parliament resumes

West Australian

time4 hours ago

  • West Australian

Government to introduce legislation for cheaper PBS medicines next week as parliament resumes

Australians could soon pay less for prescription medicines, with the government set to bring forward legislation for cheaper PBS medicines when parliament resumes next week. Anthony Albanese says he remained focused on delivering cost-of-living relief, which was a key election promise at the May 3 poll which delivered him a whopping 94-seat majority. The legislation would cut PBS medicine costs to $25 and freeze concession prices at $7.70. 'We want to focus very much on cost-of-living. That was the basis upon which we were elected,' he said on Sunday. 'The size of your bank balance shouldn't determine the quality of your healthcare. 'In the last term, we had a range of measures, and the Coalition opposed all of them. 'This term, we've already had all the changes on July 1: the increase in the minimum wage, the changes that we have made in energy bill relief, the cheaper batteries, the range of measures now, this week, we will have cheaper medicines. 'We said we would make cheaper medicines even cheaper - that is exactly what we are doing.' It would reduce the maximum cost of PBS medicines by 20 per cent from January 1 next year, which is expected to save Australians over $200 million annually. Health Minister Mark Butler said the change would make medicines for general patients the cheapest they've been since 2004. 'For pension and concession card holders we've frozen your medicine prices at a maximum price of $7.70 until the end of the decade,' Mr Butler said.

‘Never mention the war': Albanese takes ‘Fawlty Towers' approach to foreign affairs
‘Never mention the war': Albanese takes ‘Fawlty Towers' approach to foreign affairs

Sky News AU

time4 hours ago

  • Sky News AU

‘Never mention the war': Albanese takes ‘Fawlty Towers' approach to foreign affairs

On tonight's episode of Paul Murray Live, Sky News host Paul Murray discusses Prime Minister Anthony Albanese's China trip, Labor MPs obsession with social media, Sussan Ley's push to reconnect with corporate Australia and the net zero fight. '(Anthony Albanese) in his natural environment, communist China,' Mr Murray said. 'Six days of building an important relationship, which begins with the traditional backside kissing of the Chinese leader. 'Never mention the war, this is the Fawlty Towers approach to foreign affairs.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store